TolaSure Gel | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

5,247 results for “TolaSure Gel”

FDA Grants Fast Track Designation to BioMendics' TolaSure Gel for Epidermolysis Bullosa Simplex

BioMendics Advances First-in-Class Therapy for Epidermolysis Bullosa Simplex with TAMES-02 Trial

BioMendics Launches TAMES-02 Trial for First-in-Class EB Simplex Therapy TolaSure

SolasCure Initiates New Phase II Trial for Aurase Wound Gel in Chronic Wound Treatment

Sol-Gel Technologies Receives Nasdaq Extension to Regain Compliance

Hormonal Gel Shows Promise in Phase 2 Trial for Male Contraception

FDA Approves Generic Estradiol Gel for Postmenopausal Symptom Relief

ANI Pharmaceuticals Launches Estradiol Gel, 0.06% Following FDA Approval

ANI Pharmaceuticals Launches Generic Estradiol Gel, 0.06% Following FDA Approval

CAB Gel Demonstrates Efficacy in Hispanic Patients with Moderate to Severe Acne

Page 1 of 57